Literature DB >> 23606749

microRNA-125a-3p reduces cell proliferation and migration by targeting Fyn.

Lihi Ninio-Many1, Hadas Grossman, Noam Shomron, Dana Chuderland, Ruth Shalgi.   

Abstract

Fyn, a member of the Src family kinases (SFKs), has a pivotal role in cell adhesion, proliferation, migration and survival, and its overexpression is associated with several types of cancer. MicroRNAs (miRNAs) play a major role in post-transcriptional repression of protein expression. In light of the significant functions of Fyn, together with studies demonstrating miR-125a as a tumor-suppressing miRNA that is downregulated in several cancer cell types and on our bioinformatics studies presented here, we chose to examine the post-transcription regulation of Fyn by miR-125a-3p in the HEK 293T cell line. We show that Fyn expression can be dramatically reduced by elevated levels of miR-125a-3p. Following this reduction, the activity of proteins downstream of Fyn, such as FAK, paxillin and Akt (proteins known to be overexpressed in various tumors), is also reduced. On a broader level, we show that miR-125a-3p causes an arrest of the cell cycle at the G2/M stage and decreases cell viability and migration, probably in a Fyn-directed manner. The results are reinforced by control experiments conducted using Fyn siRNA and anti-miR-125a-3p, as well as by the fact that numerous cancer cell lines show a significant downregulation of Fyn after mir-125a-3p overexpression. Collectively, we conclude that miR-125a-3p has an important role in the regulation of Fyn expression and of its signaling pathway, which implies that it has a therapeutic potential in overexpressed Fyn-related diseases.

Entities:  

Keywords:  Fyn; Migration; Proliferation; miR-125a-3p; miRNA

Mesh:

Substances:

Year:  2013        PMID: 23606749     DOI: 10.1242/jcs.123414

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  28 in total

1.  miR-125a--does the difference lie in the isoform?

Authors:  Lihi Ninio-Many; Ruth Shalgi; Irit Ben-Aharon
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

2.  miR-125a-3p targetedly regulates GIT1 expression to inhibit osteoblastic proliferation and differentiation.

Authors:  Xiao-Mei Tu; Yang-Lin Gu; Guo-Qin Ren
Journal:  Exp Ther Med       Date:  2016-11-04       Impact factor: 2.447

3.  Pathway-Focused Profiling of Oligodendrocytes Over-Expressing miR-125a-3p Reveals Alteration of Wnt and Cell-to-Cell Signaling.

Authors:  Maria P Abbracchio; Davide Lecca; Davide Marangon
Journal:  Cell Mol Neurobiol       Date:  2020-04-01       Impact factor: 5.046

4.  MicroRNA-125a-3p participates in odontoblastic differentiation of dental pulp stem cells by targeting Fyn.

Authors:  Jihua Wang; Ya Zheng; Bingbing Bai; Yihua Song; Ke Zheng; Jinwen Xiao; Yi Liang; Liuliu Bao; Qiao Zhou; Lujun Ji; Xingmei Feng
Journal:  Cytotechnology       Date:  2020-01-18       Impact factor: 2.058

5.  Regulatory region genetic variation is associated with FYN expression in Alzheimer's disease.

Authors:  Jeffrey A Zahratka; Yvonne Shao; McKenzie Shaw; Kaitlin Todd; Shane V Formica; Maria Khrestian; Thomas Montine; James B Leverenz; Lynn M Bekris
Journal:  Neurobiol Aging       Date:  2016-11-15       Impact factor: 4.673

6.  Treatment with recombinant tissue plasminogen activator alters the microRNA expression profiles in mouse brain after acute ischemic stroke.

Authors:  Yan Yan Zhao; Wen An Wang; Hua Hu
Journal:  Neurol Sci       Date:  2015-03-26       Impact factor: 3.307

7.  NORAD lentivirus shRNA mitigates fibrosis and inflammatory responses in diabetic cardiomyopathy via the ceRNA network of NORAD/miR-125a-3p/Fyn.

Authors:  Ye Liu; Yikun Zhu; Sujun Liu; Jiong Liu; Xing Li
Journal:  Inflamm Res       Date:  2021-09-30       Impact factor: 4.575

8.  Tyrosine kinase FYN negatively regulates NOX4 in cardiac remodeling.

Authors:  Shouji Matsushima; Junya Kuroda; Peiyong Zhai; Tong Liu; Shohei Ikeda; Narayani Nagarajan; Shin-Ichi Oka; Takashi Yokota; Shintaro Kinugawa; Chiao-Po Hsu; Hong Li; Hiroyuki Tsutsui; Junichi Sadoshima
Journal:  J Clin Invest       Date:  2016-08-15       Impact factor: 14.808

9.  Fyn and argonaute 2 participate in maternal-mRNA degradation during mouse oocyte maturation.

Authors:  Natalie Gindi; Hadas Grossman; Hadas Bar-Joseph; Irit Miller; Luba Nemerovsky; Ron Hadas; Nava Nevo; Dalia Galiani; Nava Dekel; Ruth Shalgi
Journal:  Cell Cycle       Date:  2022-02-01       Impact factor: 5.173

10.  RNA sequencing reveals a depletion of collagen targeting microRNAs in Dupuytren's disease.

Authors:  Scott M Riester; Diren Arsoy; Emily T Camilleri; Amel Dudakovic; Christopher R Paradise; Jared M Evans; Jorge Torres-Mora; Marco Rizzo; Peter Kloen; Marianna Kruithof-de Julio; Andre J van Wijnen; Sanjeev Kakar
Journal:  BMC Med Genomics       Date:  2015-10-07       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.